Biomed Realty Trust (BMR) 23.81 $BMR Uptrend Call

New Post Public Reply Private Reply Replies (0) Message Board

Sep 8, 2016 at 1:22 AM

Biomed Realty Trust (BMR) 23.81 $BMR

Uptrend Call Working As BioMed Realty Trust Stock Rises 21.1% (BMR)
Comtex SmarTrend(R) - Fri Sep 02, 1:55PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 12 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)

Shares of BMR Up 21.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 26, 1:22AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 11 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)

21.1% Return Seen to Date on SmarTrend BioMed Realty Trust Call (BMR)
Comtex SmarTrend(R) - Thu Aug 18, 1:28AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 11 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)

BioMed Realty Trust Up 21.1% Since SmarTrend Uptrend Call (BMR)
Comtex SmarTrend(R) - Tue Jun 07, 12:48AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 9 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)

BioMed Realty Trust Shares Up 21.1% Since SmarTrend's Buy Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 12, 1:56PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)

BioMed Realty Trust Has Returned 21.1% Since SmarTrend Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 05, 1:36PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)

Blackstone completes acquisition of BioMed Realty Trust
M2 - Thu Feb 04, 7:01AM CST
BioMed Realty Trust, Inc. (NYSE: BMR) has completed its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P, valued at USD8.0 billion, the company said. Pursuant to the transaction, holders of shares of common stock of BioMed Realty will be entitled to receive USD23.8239 in cash, without interest, in exchange for each share of common stock they own. Morgan Stanley & Co. LLC acted as lead financial advisor to BioMed Realty, with Raymond James & Associates, Inc. also acting as a financial advisor in connection with this transaction. Latham & Watkins LLP acted as BioMed Realty's legal advisor. Eastdil Secured Group of Wells Fargo Securities LLC, Citigroup Global Markets Inc., JP Morgan Securities LLC, Bank of America Merrill Lynch and Goldman Sachs acted as Blackstone's financial advisors in connection with the transaction. Simpson Thacher & Bartlett LLP acted as legal advisor to Blackstone. BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. Blackstone has approximately USD92 billion in investor capital under management. Blackstone's real estate portfolio includes hotel, office, retail, industrial and residential properties in the US, Europe, Asia and Latin America.
BMR: 23.81 (+0.04), WFC: 49.77 (-0.22), MS: 31.69 (-0.06)

United Kingdom & Ireland Laboratories (All Sectors) Project Reporting Package Report 2016
M2 - Thu Jan 28, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/vxf8ml/laboratories_all) has announced the addition of the "Laboratories (All Sectors) Project Reporting Package - United Kingdom & Ireland" report to their offering. This laboratories capex project reporting package covers projects associated with the pharmaceutical/biotech throughout the UK and Ireland. All laboratories projects sit within the main process sectors and cover activities such as QA/QC, R&D and new product development (NPD). Projects range from upgrades and modifications to expansions and complete new builds, all with a breadth of scope to include a wide range of equipment as well as associated building and services aspects such as cleanrooms, HVAC, utilities and effluent treatment. One of the most important features of this project reporting is the inclusion of key decision makers which includes contacts with roles encompassing: - External consultants - Technology providers - Design - Engineering - EPC contractors - Equipment specification & selection - Procurement - Planning - Project management - Operations management Within this package there are 59 project reports which include: - Capital Expenditure > 1m - Scheduled to enter procurement phase during 2016 - Project Types: - - New Builds - - Expansions - - Upgrades - - Modifications - Facility Types - - Manufacturing Processes - - Product Development / R&D - - Controlled Storage - - Site Utilities Key Topics Covered: The following information is provided for each project: 1. Company Information - Name - Address - Phone & Fax - Web Site 2. Project Information - Sensitivity - Description - Product Type - Project Location - Project Region - Value - Status 3. Contacts 4. Schedule 5. Notes - Background - Project - Scope - Process Companies Mentioned - 4D Pharma plc - AB Agri Ltd - AarhusKarlshamn UK Ltd - Alcohols Ltd - Babraham Institute - Bartholomews Agri Food Ltd - BioMed Realty Trust Inc - Cara Partners Ltd - Catalent Pharma Solutions Ltd - Cellulac Ltd - Chinook Sciences Ltd - CooperVision Manufacturing Ltd - Cork County Council - HMG Paints Ltd - Harper Adams University - Hologic Ltd - Indivior UK Ltd - Industrial Chemicals Group Ltd - Institute for Animal Health - Keele University Science & Business Park - Merck Sharp & Dohme Ltd - Microbiological Solutions Ltd - National Centre for Food Manufacturing - Oxford Brookes University - Pochin's Ltd - Public Health England - Quantum Pharmaceutical Ltd - Royal Free Hospital NHS Trust - Sandwell & West Birmingham Hospitals - Stryker Orthopaedics - Swallowfield plc - Syngenta UK Ltd - The Centre for Process Innovation - Treatt plc - UCB Pharma Ltd For more information visit http://www.researchandmarkets.com/research/vx...tories_all
BMR: 23.81 (+0.04), MRK: 62.87 (-0.37), HOLX: 38.67 (+0.17)

Blackstone Completes Acquisition Of BioMed Realty Trust
PR Newswire - Wed Jan 27, 1:48PM CST
BioMed Realty Trust, Inc. (NYSE: BMR) (the "Company"

announced today the completion of its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P. The total transaction value is approximately $8 billion.
BMR: 23.81 (+0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI and Storytelling Make Waves in Science Education

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Geron Corp Faces Fiduciary Duty Investigation

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

AST SpaceMobile Faces Class Action Over Misstatements

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

PACS Group Faces Legal Scrutiny: What to Watch

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Quay Sunglasses: Luxury Looks, Affordable Prices

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Cut Winter Heating Costs with Townsend's Rebate Help

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

HONA Faces Legal Heat: Investor Lawsuit Over Losses

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Endurance Energy's Modular Tech Revs Up Southeast Asia

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

CVS Health Under Fire: Fiduciary Duty Breach?

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...